Portage Biotech Stock Price on January 2, 2024

PRTG Stock  USD 4.11  0.13  3.27%   
Below is the normalized historical share price chart for Portage Biotech extending back to July 27, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Portage Biotech stands at 4.11, as last reported on the 4th of December, with the highest price reaching 4.15 and the lowest price hitting 3.92 during the day.
IPO Date
25th of February 2021
200 Day MA
6.0614
50 Day MA
5.5903
Beta
99.478
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Portage Stock, it is important to understand the factors that can impact its price. Portage Biotech is dangerous given 3 months investment horizon. Portage Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.0735, which implies the firm had a 0.0735% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.25% are justified by taking the suggested risk. Use Portage Biotech Semi Deviation of 7.29, risk adjusted performance of 0.0617, and Coefficient Of Variation of 1463.58 to evaluate company specific risk that cannot be diversified away.
  
At this time, Portage Biotech's Stock Based Compensation is most likely to increase significantly in the upcoming years. The Portage Biotech's current Issuance Of Capital Stock is estimated to increase to about 9.9 M, while Liabilities And Stockholders Equity is projected to decrease to roughly 7.4 M. . The current Price To Sales Ratio is estimated to decrease to 1,972. The current Price Earnings Ratio is estimated to decrease to -3.14. Portage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0735

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsPRTG
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 16.97
  actual daily
96
96% of assets are less volatile

Expected Return

 1.25
  actual daily
24
76% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average Portage Biotech is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Portage Biotech by adding it to a well-diversified portfolio.
Price Book
3.1916
Book Value
4.066
Enterprise Value
2.8 M
Enterprise Value Ebitda
(0.02)
Shares Float
595.2 K

Portage Biotech Valuation on January 2, 2024

It is possible to determine the worth of Portage Biotech on a given historical date. On January 2, 2024 Portage was worth 36.8 at the beginning of the trading date compared to the closed value of 37.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Portage Biotech stock. Still, in general, we apply an absolute valuation method to find Portage Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Portage Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Portage Biotech's related companies.
 Open High Low Close Volume
  34.80    37.59    32.87    36.40    1,403  
01/02/2024
  36.80    40.80    36.70    37.80    3,501  
  38.01    38.01    28.20    28.20    1,009  
Backtest Portage Biotech  |  Portage Biotech History  |  Portage Biotech Valuation   PreviousNext  
Open Value
36.8
37.8
Closing Value
87.70
Upside

Portage Biotech Trading Date Momentum on January 2, 2024

On January 03 2024 Portage Biotech was traded for  28.20  at the closing time. The top price for the day was 38.01  and the lowest listed price was  28.20 . The trading volume for the day was 1 K. The trading history from January 3, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 25.40% . The trading delta at closing time against the current closing price is 37.12% .

Portage Biotech Fundamentals Correlations and Trends

By evaluating Portage Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Portage Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Portage financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Portage Biotech Stock history

Portage Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Portage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Portage Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Portage Biotech stock prices may prove useful in developing a viable investing in Portage Biotech
Last ReportedProjected for Next Year
Common Stock Shares Outstanding20.3 M21.4 M
Net Loss-15.2 M-14.4 M

Portage Biotech Quarterly Net Working Capital

2.19 Million

Portage Biotech Stock Technical Analysis

Portage Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Portage Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Portage Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Portage Biotech Period Price Range

Low
December 4, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Portage Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Portage Biotech December 4, 2024 Market Strength

Market strength indicators help investors to evaluate how Portage Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Portage Biotech shares will generate the highest return on investment. By undertsting and applying Portage Biotech stock market strength indicators, traders can identify Portage Biotech entry and exit signals to maximize returns

Portage Biotech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Portage Biotech's price direction in advance. Along with the technical and fundamental analysis of Portage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Portage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Portage Stock analysis

When running Portage Biotech's price analysis, check to measure Portage Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Portage Biotech is operating at the current time. Most of Portage Biotech's value examination focuses on studying past and present price action to predict the probability of Portage Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Portage Biotech's price. Additionally, you may evaluate how the addition of Portage Biotech to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance